Evidence map›Paper›PMID 27957023›Full record

ArticleGastroenterology research2011

Proton Pump Inhibitors Interfere With Zinc Absorption and Zinc Body Stores.

Christopher P Farrell, Melissa Morgan, David S Rudolph, Austin Hwang, Nicole E Albert, Mary C Valenzano, Xuexuan Wang, Giancarlo Mercogliano, James M Mullin

Open access · hybridAbstract read
In one paragraph

Article in Gastroenterology research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Zinc and gastrointestinal disease.World journal of gastrointestinal pathophysiology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Christopher P FarrellDepartment of Gastrointestinal Medicine, Lankenau Medical Center, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.
Melissa MorganDepartment of Gastrointestinal Medicine, Lankenau Medical Center, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.
David S RudolphDepartment of Gastrointestinal Medicine, Lankenau Medical Center, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.
Austin HwangDepartment of Gastrointestinal Medicine, Lankenau Medical Center, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.
Nicole E AlbertDepartment of Internal Medicine, Lankenau Medical Center, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.
Mary C ValenzanoLankenau Institute for Medical Research, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.
Xuexuan WangLankenau Institute for Medical Research, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.
Giancarlo MercoglianoDepartment of Gastrointestinal Medicine, Lankenau Medical Center, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.
James M MullinDepartment of Gastrointestinal Medicine, Lankenau Medical Center, 100 Lancaster Avenue, Wynnewood, PA 19096, USA; Lankenau Institute for Medical Research, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.
Lankenau Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProton pump inhibitors (PPIs) cause a sharp elevation of gastro-duodenal luminal pH which in turn has resulted in reports of reduced absorption of magnesium and certain other nutrients.

methodsGastroesophageal reflux disease (GERD) patients on long-term PPI therapy (> 6 months) or healthy test subjects (not on any acid preventive or neutralizing medication) were administered oral doses of zinc gluconate (26.2 mg zinc, twice daily) for 14 days followed by 5 cc venous blood samples. Plasma was analyzed for total zinc content by atomic absorption spectrophotometry. Baseline plasma and red blood cell zinc levels were also measured in these two groups when not taking any zinc supplementation.

resultsPlasma zinc levels of healthy controls increased by 126% during the period of zinc supplementation compared to only a 37% increase for individuals on long-term PPI therapy. On their normal diet (with no zinc supplementation), PPI-users had a 28% lower plasma zinc level than healthy controls (P < 0.005).

conclusionsPPI use dramatically reduces supplemental zinc uptake and can result in decreased zinc body stores. Certain individuals on long-term PPI therapy, such as infants being treated for colic, may be at risk for decreased systemic levels of trace metals needed for developmental, regenerative and immunological requirements.

Indexed as

AcidColicIntestineNutritionpHProton pump inhibitorStomachTrace metalZinc

Identifiers

PMID27957023
PMCPMC5139861
OpenAlexW2156403160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.